A comparison of alprazolam and behavior therapy in treatment of panic disorder.
The results of a clinical outcome study (N = 57) comparing behavior therapy directed at panic disorder (panic control treatment [PCT]) with alprazolam were reported. These conditions were compared with a medication placebo and a waiting-list control group. Patterns of results on measures of panic attacks, generalized anxiety, and global clinical ratings reveal that PCT was significantly more effective than placebo and waiting-list conditions on most measures. The alprazolam group differed significantly from neither PCT nor placebo. The percentage of clients completing the study who were free of panic attacks following PCT was 87%, compared with 50% for alprazolam, 36% for placebo, and 33% for the waiting-list group. Since alprazolam may work more quickly than PCT but may also interfere with the effects of behavioral treatment, these data suggest a series of studies on the feasibility of integrating these treatments and on the precise patterns and mechanisms of action of various successful treatment approaches to panic disorder.
Klosko
J S
JS
Center for Stress and Anxiety Disorders, State University of New York, Albany.
Barlow
D H
DH
Tassinari
R
R
Cerny
J A
JA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000525:Alprazolam / Q000494:pharmacology / Q000627:therapeutic use*; D000704:Analysis of Variance; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy*; D001521:Behavior Therapy; D016009:Chi-Square Distribution; D005239:Fear / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010352:Patient Dropouts
D000525:Alprazolam